| 1 | [SID49671814] | Active | Potency | 35.4813 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 2 | [SID49671814] | Active | Potency | 35.4813 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 3 | [SID49671814] | Active | Potency | 50.1187 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 4 | [SID49671814] | Active | Potency | 50.1187 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 5 | [SID49671814] | Active | Potency | 79.4328 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 6 | [SID49671814] | Active | | | Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Active | | BioAssay | Aqueous Solubility from MLSMR Stock Solutions | | AID | 1996 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID49671814] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 8 | [SID49671814] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 9 | [SID49671814] | Inactive | Potency | 1 | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 10 | [SID49671814] | Inactive | Potency | | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1721, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1721 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 11 | [SID49671814] | Inactive | Potency | | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1722, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1722 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 12 | [SID49671814] | Inactive | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 13 | [SID49671814] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 14 | [SID49671814] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 15 | [SID49671814] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 16 | [SID49671814] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 17 | [SID49671814] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 18 | [SID49671814] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 19 | [SID49671814] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 20 | [SID49671814] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 21 | [SID49671814] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 22 | [SID49671814] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 23 | [SID49671814] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 24 | [SID49671814] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 25 | [SID49671814] | Inactive | | | RNA aptamer-based HTS for inhibitors of GRK2 [AID488847, Type: screening] | beta-adrenergic receptor kinase 1 [Homo sapiens] [gi:148539876] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | RNA aptamer-based HTS for inhibitors of GRK2 | | AID | 488847 | | BioAssay type | screening | | Target | beta-adrenergic receptor kinase 1 [Homo sapiens] [gi:148539876] | | PubMed | | | Data Table |  |
|
| 26 | [SID49671814] | Inactive | | | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay [AID2520, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2520 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 27 | [SID49671814] | Inactive | | | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay [AID2520, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2520 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 28 | [SID49671814] | Inactive | | | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2521, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2521 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 29 | [SID49671814] | Inactive | | | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2521, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2521 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 30 | [SID49671814] | Inactive | | | Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1) [AID504766, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1) | | AID | 504766 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 31 | [SID49671814] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 32 | [SID49671814] | Inactive | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 33 | [SID49671814] | Inactive | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 34 | [SID49671814] | Inactive | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 35 | [SID49671814] | Inactive | | | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen [AID651550, Type: screening] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen | | AID | 651550 | | BioAssay type | screening | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 36 | [SID49671814] | Inactive | | | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen [AID651550, Type: screening] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen | | AID | 651550 | | BioAssay type | screening | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 37 | [SID49671814] | Inactive | | | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen [AID651550, Type: screening] | RAC-alpha serine/threonine-protein kinase [gi:60391226] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen | | AID | 651550 | | BioAssay type | screening | | Target | RAC-alpha serine/threonine-protein kinase [gi:60391226] | | PubMed | | | Data Table |  |
|
| 38 | [SID49671814] | Inactive | | | uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase [AID2524, Type: screening] | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase | | AID | 2524 | | BioAssay type | screening | | Target | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] | | PubMed | | | Data Table |  |
|
| 39 | [SID49671814] | Inactive | | | uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase [AID2524, Type: screening] | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase | | AID | 2524 | | BioAssay type | screening | | Target | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] | | PubMed | | | Data Table |  |
|
| 40 | [SID49671814] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase [AID2544, Type: screening] | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase | | AID | 2544 | | BioAssay type | screening | | Target | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] | | PubMed | | | Data Table |  |
|
| 41 | [SID49671814] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase [AID2544, Type: screening] | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase | | AID | 2544 | | BioAssay type | screening | | Target | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] | | PubMed | | | Data Table |  |
|
| 42 | [SID49671814] | Inactive | | | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID489030, Type: screening] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 | | AID | 489030 | | BioAssay type | screening | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 43 | [SID49671814] | Inactive | | | uHTS Fluorescent assay for identification of activators of Apaf-1 [AID489031, Type: screening] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent assay for identification of activators of Apaf-1 | | AID | 489031 | | BioAssay type | screening | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 44 | [SID49671814] | Inactive | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 45 | [SID49671814] | Inactive | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 46 | [SID49671814] | Inactive | | | Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling [AID504490, Type: screening] | Arrestin, beta 1 [Homo sapiens] [gi:13177715] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling | | AID | 504490 | | BioAssay type | screening | | Target | Arrestin, beta 1 [Homo sapiens] [gi:13177715] | | PubMed | | | Data Table |  |
|
| 47 | [SID49671814] | Inactive | Potency | | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia [AID485349, Type: confirmatory] | serine-protein kinase ATM [Homo sapiens] [gi:71902540] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia | | AID | 485349 | | BioAssay type | confirmatory | | Target | serine-protein kinase ATM [Homo sapiens] [gi:71902540] | | PubMed | | | Data Table |  |
|
| 48 | [SID49671814] | Inactive | Potency | | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia [AID485349, Type: confirmatory] | serine-protein kinase ATM [Homo sapiens] [gi:71902540] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia | | AID | 485349 | | BioAssay type | confirmatory | | Target | serine-protein kinase ATM [Homo sapiens] [gi:71902540] | | PubMed | | | Data Table |  |
|
| 49 | [SID49671814] | Inactive | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 50 | [SID49671814] | Inactive | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49671814 | | CID | 54694101 | | Outcome | Inactive | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|